Literature DB >> 20657615

Molecular methods for the diagnosis and characterization of Cryptococcus: a review.

José Júlio Costa Sidrim1, Ana Karoline Freire Costa, Rossana Aguiar Cordeiro, Raimunda Sâmia Nogueira Brilhante, Fernanda Edna Araújo Moura, Débora Souza Collares Maia Castelo-Branco, Manoel Paiva de Araújo Neto, Marcos Fábio Gadelha Rocha.   

Abstract

Cryptococcosis is a fungal infection caused by yeasts of the genus Cryptococcus, with Cryptococcus neoformans and Cryptococcus gattii as the primary pathogenic species. This disease is a threat to immunocompromised patients, especially those who have AIDS. However, the disease has also been described in healthy individuals. The tests used to identify these microorganisms have limitations that make final diagnosis difficult. However, currently there are specific gene sequences that can be used to detect C. neoformans and C. gattii from clinical specimens and cultures. These sequences can be used for identification, typing, and the study of population genetics. Among the main identification techniques are hybridization, which was the pioneer in molecular identification and development of specific probes for pathogen detection; PCR and other PCR-based methods, particularly nested PCR and multiplex PCR; and sequencing of specific genomic regions that are amplified through PCR, which is especially useful for diagnosis of cryptococcosis caused by unconventional Cryptococcus sp. Concerning microorganism typing, the following techniques have shown the best ability to differentiate between fungal serotypes and molecular types: PCR fingerprinting, PCR-RFLP, AFLP, and MLST. Thus, the accumulation of data generated by molecular methods can have a positive impact on monitoring resistant strains and treating diseases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20657615     DOI: 10.1139/w10-030

Source DB:  PubMed          Journal:  Can J Microbiol        ISSN: 0008-4166            Impact factor:   2.419


  14 in total

1.  High-resolution melting analysis for identification of the Cryptococcus neoformans-Cryptococcus gattii complex.

Authors:  Sara Gago; Óscar Zaragoza; Isabel Cuesta; Juan L Rodríguez-Tudela; Manuel Cuenca-Estrella; María J Buitrago
Journal:  J Clin Microbiol       Date:  2011-08-10       Impact factor: 5.948

2.  Identification of the environmental source of infection for a domestic ferret with cryptococcosis.

Authors:  Laura J Schmertmann; Alison Wardman; Laura Setyo; Alex Kan; Wieland Meyer; Richard Malik; Mark B Krockenberger
Journal:  J Vet Diagn Invest       Date:  2019-09-24       Impact factor: 1.279

3.  Targeting novel genes for simultaneous detection of five fungal and bacterial agents from BAL samples using multiplex PCR assay.

Authors:  Reza Kamali Kakhki; Mohammad Javad Najafzadeh; Reza Kachuei; Kiarash Ghazvini
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-04-06       Impact factor: 3.267

Review 4.  Cryptococcus gattii infections.

Authors:  Sharon C-A Chen; Wieland Meyer; Tania C Sorrell
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

5.  Pleural involvement in cryptococcal infection.

Authors:  Vasiliki E Georgakopoulou; Christos Damaskos; Pagona Sklapani; Nikolaos Trakas; Aikaterini Gkoufa
Journal:  World J Clin Cases       Date:  2022-06-06       Impact factor: 1.534

6.  Matrix-assisted laser desorption ionization-time of flight mass spectrometry-based method for discrimination between molecular types of Cryptococcus neoformans and Cryptococcus gattii.

Authors:  Brunella Posteraro; Antonietta Vella; Massimo Cogliati; Elena De Carolis; Ada Rita Florio; Patrizia Posteraro; Maurizio Sanguinetti; Anna Maria Tortorano
Journal:  J Clin Microbiol       Date:  2012-05-09       Impact factor: 5.948

7.  Granulomatous Sarcoidosis Mimics.

Authors:  Marc A Judson
Journal:  Front Med (Lausanne)       Date:  2021-07-08

8.  MALDI-TOF MS enables the rapid identification of the major molecular types within the Cryptococcus neoformans/C. gattii species complex.

Authors:  Carolina Firacative; Luciana Trilles; Wieland Meyer
Journal:  PLoS One       Date:  2012-05-29       Impact factor: 3.240

9.  Comparison of primers for RAPD-PCR from environmental isolates of Cryptococcus neoformans, Cryptococcus albidus and Cryptococcus laurentii complex.

Authors:  Reginaldo Dos Santos Pedroso; Joseane Cristina Ferreira; Karen Regina Carim da Costa; Regina Celia Candido
Journal:  Braz J Microbiol       Date:  2012-06-01       Impact factor: 2.476

10.  Treatment and outcomes among patients with Cryptococcus gattii infections in the United States Pacific Northwest.

Authors:  Rachel M Smith; Adamma Mba-Jonas; Mathieu Tourdjman; Trisha Schimek; Emilio DeBess; Nicola Marsden-Haug; Julie R Harris
Journal:  PLoS One       Date:  2014-02-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.